These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1838105)

  • 21. A prospective study comparing vancomycin and teicoplanin as second-line empiric therapy for infection in neutropenic patients.
    Cony-Makhoul P; Brossard G; Marit G; Pellegrin JL; Texier-Maugein J; Reiffers J
    Br J Haematol; 1990 Dec; 76 Suppl 2():35-40. PubMed ID: 2149050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nosocomial meningitis caused by Staphylococcus haemolyticus in a child with neutropenia in the absence of intracranial devices: a case report.
    Mizuno S; Fujikawa T; Uemura S; Hasegawa D; Kosaka Y; Kasai M
    BMC Infect Dis; 2023 Feb; 23(1):95. PubMed ID: 36788492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycopeptide-induced vasculitis--cross-reactivity between vancomycin and teicoplanin.
    Marshall C; Street A; Galbraith K
    J Infect; 1998 Jul; 37(1):82-3. PubMed ID: 9733391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised hosts.
    Van der Auwera P; Aoun M; Meunier F
    Antimicrob Agents Chemother; 1991 Mar; 35(3):451-7. PubMed ID: 1828134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nephrotoxicity of vancomycin in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
    Shen WC; Chiang YC; Chen HY; Chen TH; Yu FL; Tang CH; Sue YM
    Nephrology (Carlton); 2011 Nov; 16(8):697-703. PubMed ID: 21707841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vancomycin-induced neutropenia resolves after substitution with teicoplanin.
    Sanche SE; Dust WN; Shevchuk YM
    Clin Infect Dis; 2000 Sep; 31(3):824-5. PubMed ID: 11017842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of glycopeptides in the treatment of infections caused by methicillin-resistant staphylococci].
    Bouza E; Rodríguez-Créixems M; Muñoz P
    Rev Clin Esp; 1997 Sep; 197 Suppl 2():52-8. PubMed ID: 9441324
    [No Abstract]   [Full Text] [Related]  

  • 28. A closer look at vancomycin, teicoplanin, and antimicrobial resistance.
    Zeckel ML
    J Chemother; 1997 Oct; 9(5):311-31; discussion 332-5. PubMed ID: 9373787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antistaphylococcal activities of teicoplanin and vancomycin in vitro and in an experimental infection.
    Peetermans WE; Hoogeterp JJ; Hazekamp-van Dokkum AM; van den Broek P; Mattie H
    Antimicrob Agents Chemother; 1990 Oct; 34(10):1869-74. PubMed ID: 2149812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of teicoplanin treatment associated with an increase in MIC during therapy of Staphylococcus aureus septicaemia.
    Manquat G; Croize J; Stahl JP; Meyran M; Hirtz P; Micoud M
    J Antimicrob Chemother; 1992 Jun; 29(6):731-2. PubMed ID: 1387135
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative efficacy of vancomycin and teicoplanin in the treatment of hospitalised elderly patients with persistent meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia.
    Lin SH; Lai CC; Tan CK; Liao WH; Hsueh PR
    Int J Antimicrob Agents; 2011 Feb; 37(2):179-81. PubMed ID: 21163634
    [No Abstract]   [Full Text] [Related]  

  • 32. The role of gram-positive therapy in the neutropenic patient.
    Menichetti F; Del Favero A
    J Antimicrob Chemother; 1991 Apr; 27 Suppl B():51-60. PubMed ID: 1829077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results.
    Van Laethem Y; Hermans P; De Wit S; Goosens H; Clumeck N
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():81-7. PubMed ID: 2965135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-vitro induction of resistance in coagulase-negative staphylococci to vancomycin and teicoplanin.
    Watanakunakorn C
    J Antimicrob Chemother; 1988 Sep; 22(3):321-4. PubMed ID: 2972670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolerance to the glycopeptides vancomycin and teicoplanin in coagulase-negative staphylococci.
    Bourgeois I; Pestel-Caron M; Lemeland JF; Pons JL; Caron F
    Antimicrob Agents Chemother; 2007 Feb; 51(2):740-3. PubMed ID: 17116684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selection of vancomycin- and teicoplanin-resistant Staphylococcus haemolyticus during teicoplanin treatment of S. epidermidis infection.
    Aubert G; Passot S; Lucht F; Dorche G
    J Antimicrob Chemother; 1990 Mar; 25(3):491-3. PubMed ID: 2140112
    [No Abstract]   [Full Text] [Related]  

  • 37. Combination of vancomycin and rifampicin for the treatment of persistent coagulase-negative staphylococcal bacteremia in preterm neonates.
    Rodriguez-Guerineau L; Salvia-Roigés MD; León-Lozano M; Rodríguez-Miguélez JM; Figueras-Aloy J
    Eur J Pediatr; 2013 May; 172(5):693-7. PubMed ID: 23328960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
    Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Gaona Álvarez C; Sánchez Silos RM; Hernández Rastrollo R; Martínez Tallo E; Cordero Carrasco JL
    Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment evaluation of experimental staphylococcal infections: comparison of beta-lactam, lipopeptide, and glycopeptide antimicrobial therapy.
    Fasching CE; Peterson LR; Moody JA; Sinn LM; Gerding DN
    J Lab Clin Med; 1990 Nov; 116(5):697-706. PubMed ID: 1967132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative effectiveness of linezolid versus vancomycin as definitive antibiotic therapy for heterogeneously resistant vancomycin-intermediate coagulase-negative staphylococcal central-line-associated bloodstream infections in a neonatal intensive care unit.
    Blanchard AC; Fortin E; Laferrière C; Goyer I; Moussa A; Autmizguine J; Quach C
    J Antimicrob Chemother; 2017 Jun; 72(6):1812-1817. PubMed ID: 28333257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.